Colleen Harris - Ramsay Health Group Officer
| RHC Stock | 39.56 0.21 0.53% |
Executive
Colleen Harris is Group Officer of Ramsay Health Care
| Age | 56 |
| Address | 126 Phillip Street, Sydney, NSW, Australia, 2000 |
| Phone | 61 2 9220 1000 |
| Web | https://www.ramsayhealth.com |
Ramsay Health Management Efficiency
The company has return on total asset (ROA) of 0.028 % which means that it generated a profit of $0.028 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0509 %, meaning that it generated $0.0509 on every $100 dollars invested by stockholders. Ramsay Health's management efficiency ratios could be used to measure how well Ramsay Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Ramsay Health's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 22.4 B in 2024, whereas Non Current Liabilities Other is likely to drop slightly above 704.4 M in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Andrew Cartledge | WiseTech Global Limited | N/A | |
| Brian Kaplan | Cochlear | N/A | |
| Mike Sverdlov | WiseTech Global Limited | N/A | |
| Angad Soin | Xero | N/A | |
| Dave Ross | CSL | N/A | |
| Karen Etchberger | CSL | 66 | |
| Joseph Lyons | Xero | N/A | |
| Dean Phizacklea | Cochlear | N/A | |
| Nicole Mehalski | Xero | N/A | |
| AMCT BA | Macquarie Group | 59 | |
| Steve Maidment | Rea Group | N/A | |
| Andy Schmeltz | CSL | 53 | |
| Jennifer Hornery | Cochlear | N/A | |
| Anthony Waldron | Rea Group | N/A | |
| Gene Gander | WiseTech Global Limited | N/A | |
| MPH MD | CSL | 65 | |
| Ian Larsen | WiseTech Global Limited | N/A | |
| Mark Rees | Xero | N/A | |
| Kul Singh | Rea Group | N/A | |
| Chris Cooper | CSL | N/A | |
| Karen ODriscoll | Cochlear | N/A | |
Management Performance
| Return On Equity | 0.0509 | ||||
| Return On Asset | 0.028 |
Ramsay Health Care Leadership Team
Elected by the shareholders, the Ramsay Health's board of directors comprises two types of representatives: Ramsay Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ramsay. The board's role is to monitor Ramsay Health's management team and ensure that shareholders' interests are well served. Ramsay Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ramsay Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andrew Wearne, Group Officer | ||
| Joy Chamberlain, Chief Healthcare | ||
| BECON LLB, Group Secretary | ||
| LLB BECON, Group Secretary | ||
| Carmel Monaghan, Chief Australia | ||
| Kelly Hibbins, Group Relations | ||
| Andrew Jones, Group Officer | ||
| Craig McNally, MD CEO | ||
| Martyn Roberts, Group Officer | ||
| Rachna Gandhi, Global Officer | ||
| Pascal Roche, CEO Sant | ||
| Doug Meagher, CFO Australia | ||
| Colleen Harris, Group Officer | ||
| Nick Costa, Chief UK | ||
| AC DSc, Group Officer | ||
| Kah Hong, Group Care |
Ramsay Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ramsay Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0509 | ||||
| Return On Asset | 0.028 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 19.38 B | ||||
| Shares Outstanding | 230.25 M | ||||
| Shares Owned By Insiders | 20.39 % | ||||
| Shares Owned By Institutions | 40.63 % | ||||
| Price To Book | 1.86 X | ||||
| Price To Sales | 0.54 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Ramsay Stock Analysis
When running Ramsay Health's price analysis, check to measure Ramsay Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ramsay Health is operating at the current time. Most of Ramsay Health's value examination focuses on studying past and present price action to predict the probability of Ramsay Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ramsay Health's price. Additionally, you may evaluate how the addition of Ramsay Health to your portfolios can decrease your overall portfolio volatility.